These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 18774012)

  • 21. How are European patients at risk of malignant arrhythmias or sudden cardiac death identified and informed about their risk profile: results of the European Heart Rhythm Association survey.
    Proclemer A; Bongiorni MG; Dagres N; Sciaraffia E; Todd D; Blomstrom-Lundqvist C;
    Europace; 2015 Jun; 17(6):994-8. PubMed ID: 26023178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.
    Piccini JP; Al-Khatib SM; Myers ER; Anstrom KJ; Buxton AE; Peterson ED; Sanders GD
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):791-8. PubMed ID: 20132397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial fibrosis predicts ventricular tachyarrhythmias.
    Disertori M; Masè M; Ravelli F
    Trends Cardiovasc Med; 2017 Jul; 27(5):363-372. PubMed ID: 28262437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sudden cardiac death.
    Sra J
    Indian Heart J; 1999; 51(2):137-59. PubMed ID: 10407542
    [No Abstract]   [Full Text] [Related]  

  • 25. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiac magnetic resonance findings in a case of carnitine deficiency.
    Ascunce RR; Nayar AC; Phoon CK; Srichai MB
    Tex Heart Inst J; 2013; 40(1):104-5. PubMed ID: 23468586
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnosis and management of sudden cardiac death.
    Spector PS
    Heart; 2005 Mar; 91(3):408-13. PubMed ID: 15710742
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of implantable cardioverter defibrillator and cardiac resynchronization therapy: an Italian survey study on 220 cardiology departments.
    Inama G; Pedrinazzi C; Landolina M; Oliva F; Senni M; Proclemer A; Berisso MZ; Pirelli S;
    J Cardiovasc Med (Hagerstown); 2012 Nov; 13(11):675-83. PubMed ID: 22002257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sudden cardiac death and implantable cardioverter-defibrillators.
    Turakhia MP
    Am Fam Physician; 2010 Dec; 82(11):1357-66. PubMed ID: 21121520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [ICD-implantation--for which patients is its value for primary prevention secure?].
    Fiek M; Reithmann C; Steinbeck G
    Dtsch Med Wochenschr; 2006 Sep; 131(39):2165-8. PubMed ID: 16991035
    [No Abstract]   [Full Text] [Related]  

  • 31. Rhythm disorders in isolated left ventricular noncompaction.
    Steffel J; Duru F
    Ann Med; 2012 Mar; 44(2):101-8. PubMed ID: 21639721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk stratification in nonischemic dilated cardiomyopathy: Current perspectives.
    Okutucu S; Oto A
    Cardiol J; 2010; 17(3):219-29. PubMed ID: 20535711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sudden cardiac death: an 11-year postmortem analysis in the region of Epirus, Greece.
    Fragkouli K; Vougiouklakis T
    Pathol Res Pract; 2010 Oct; 206(10):690-4. PubMed ID: 20932458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk stratification of ventricular arrhythmias in patients with systolic heart failure.
    Vest RN; Gold MR
    Curr Opin Cardiol; 2010 May; 25(3):268-75. PubMed ID: 20224387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score.
    van Rees JB; Borleffs CJ; van Welsenes GH; van der Velde ET; Bax JJ; van Erven L; Putter H; van der Bom JG; Schalij MJ
    Heart; 2012 Jun; 98(11):872-7. PubMed ID: 22581736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arrhythmic risk stratification in non-ischemic dilated cardiomyopathy: Where do we stand after DANISH?
    Dilaveris P; Antoniou CK; Gatzoulis KA
    Trends Cardiovasc Med; 2017 Nov; 27(8):542-555. PubMed ID: 28709811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sudden death risk stratification in non-ischemic dilated cardiomyopathy using old and new tools: a clinical challenge.
    Manolis AS
    Expert Rev Cardiovasc Ther; 2017 Apr; 15(4):315-325. PubMed ID: 28292197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive risk stratification for sudden death: signal-averaged electrocardiography, nonsustained ventricular tachycardia, heart rate variability, baroreflex sensitivity, and QRS duration.
    Stein KM
    Prog Cardiovasc Dis; 2008; 51(2):106-17. PubMed ID: 18774010
    [No Abstract]   [Full Text] [Related]  

  • 39. Implantable Defibrillator Timing Windows: When Coincidence Can Be Confusing.
    Jackson N; Viswanathan K; Cameron D; Nair K
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002876. PubMed ID: 26902146
    [No Abstract]   [Full Text] [Related]  

  • 40. Sudden death secondary to cardiac arrhythmias: mechanisms and treatment strategies.
    Siddiqui A; Kowey PR
    Curr Opin Cardiol; 2006 Sep; 21(5):517-25. PubMed ID: 16900017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.